Jade Biosciences, Inc. (JBIO) › Cash & EquivalentsJade Biosciences, Inc. (JBIO) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2020-12-31: $4.57M2021-12-31: $54.20M2022-12-31: $22.40M2023-12-31: $23.49M2024-12-31: $69.39M2025-12-31: $88.44M$88.44M2020-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$88.44M+27.5%2026-03-06Balance as of period end2024-12-31$69.39M+195.4%2026-03-06Balance as of period end2023-12-31$23.49M+4.9%2025-03-27Balance as of period end2022-12-31$22.40M-58.7%2024-03-25Balance as of period end2021-12-31$54.20M+1085.2%2023-03-29Balance as of period end2020-12-31$4.57M—2022-03-30Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)